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Background
In the central nervous system, levels of extraneuronal
dopamine are controlled primarily by the action of the
dopamine transporter (DAT). Multiple signaling path-
ways regulate transport activity, substrate efflux, and
other DAT functions through currently unknown
mechanisms but presumably by oligomerization, pro-
tein-protein interactions and post-translational modifica-
tion, such as phosphorylation. DAT is phosphorylated
by protein kinase C within a serine cluster at the distal
end of the cytoplasmic N-terminus, while recent work
in model cells revealed proline-directed phosphorylation
of rat DAT at membrane proximal residue Thr53. How-
ever, specific phosphorylation sites in native DAT under
basal condition with associated functional properties
have not been ascertained so far.
Methods
We (i) applied mass spectrometry in rodent striatal tissue
and heterologous cell systems to identify in vivo phosphor-
ylation sites (ii) generated a phospho-specific antibody
(pT53Ab) for the confirmation of the identified phosphor-
ylation site and for the determination of a stoichiometry of
phosphorylation, involvement of PKC and phosphatase.
Functional implications of this identified phosphorylation
site have been tested by dopamine uptake and ampheta-
mine-stimulated substrate efflux.
Results
Phosphorylation of Thr53 (pThr53), occurred with a
stoichiometry of ~50% under basal condition in rat
striatal tissue, was unambiguously identified by mass
spectrometry and immunoassay with phospho-specific
antibody. pThr53 was strongly increased by phorbol
esters and protein phosphatase inhibitors. Mutations of
Thr53 to alanine to mimic dephosphorylation reduced
dopamine transport Vmax and ablated amphetamine-
induced substrate efflux.
Conclusions
DAT is constitutively phosphorylated at Thr53 and its
phosphorylation/dephosphorylation status plays a role in
the transport mechanism, particularly in dopamine
uptake and amphetamine-stimulated substrate efflux.
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